Skip to main content
. 2021 Jul;13(7):3969–3978. doi: 10.21037/jtd-21-281

Table 2. Operative data of the study patients.

Variables BMVR group (n=241) PMVR group (n=68) P value
CPB time (minutes) 228.6±74.5 208.7±82.4 0.060
ACC time (minutes) 153.6±51.0 133.0±44.9 0.003
Prosthetic valve size, n (%) 0.13
   21 1 (0.4) 0 (0.0)
   23 4 (1.7) 0 (0.0)
   25 71 (29.5) 21 (30.9)
   27 57 (23.7) 26 (38.2)
   29 70 (29.0) 17 (25.0)
   31 33 (13.7) 3 (4.4)
   33 5 (2.1) 1 (1.4)
Concomitant procedure, n (%)
   Aortic valve procedure 99 (41.1) 11 (16.2) <0.001
    Bioprosthetic valve replacement 92 (38.2) 10 (14.7)
    Mechanical valve replacement 1 (0.4) 1 (1.5)
    Repair 6 (2.5) 0 (0.0)
   Tricuspid valve procedure 119 (49.4) 14 (20.6) <0.001
    Bioprosthetic valve replacement 13 (5.4) 3 (4.4)
    Mechanical valve replacement 0 (0.0) 0 (0.0)
    Repair 116 (48.1) 11 (16.2)
   Arrhythmia surgery 74 (30.7) 33 (48.5) 0.006
   CABG 13 (5.4) 4 (7.4) 0.54

BMVR, mitral valve replacement with Carpentier-Edwards PERIMOUNT bovine pericardial valves; PMVR, mitral valve replacement with Hancock II porcine bioprostheses; ACC, aortic cross clamp; CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting.